Ticker
Reporting Basis
Interim
Annual
Period
Last 10
Last 9
Last 8
Last 7
Last 6
Last 5
Last 4
Last 3
Last 2
Last 1
Other
From
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
To
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Form Type
Income Statement
Balance Sheet
Cash Flow
Segment Info
General Info
Metrics
Report Format
Standard
Company Specific
Update Type
Most Recent
Orig. Reported
ICU MEDICAL INC FYE=12 (December)
Annual - Income Statement - Company Specific
Fiscal period
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
Period End Date
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Sales
2,382.05
2,259.13
2,280.00
1,316.31
1,271.00
1,266.21
1,400.04
1,292.17
379.34
341.25
Revenue- Other
--
--
--
--
--
--
--
0.45
0.03
0.41
Total Revenues
2,382.05
2,259.13
2,280.00
1,316.31
1,271.00
1,266.21
1,400.04
1,292.61
379.37
341.67
Cost of goods sold
1,557.26
1,519.25
1,582.24
824.82
809.51
794.34
830.01
866.52
177.97
160.87
Gross Profit
824.78
739.87
697.76
491.49
461.50
471.86
570.03
426.10
201.40
180.80
Research and development
88.62
85.34
92.98
47.50
42.95
48.61
52.87
51.25
12.96
15.71
Selling, general and administrative
638.76
606.69
608.35
302.58
283.95
276.98
328.15
303.95
89.43
83.22
Restructuring charges
59.84
41.26
71.42
18.04
28.41
80.57
105.39
77.97
15.35
8.45
Contract settlement
--
--
--
--
0.98
(5.74)
(41.61)
--
--
--
Impairment of assets held for sale
--
--
--
--
--
--
--
--
(0.73)
(4.14)
Gain (loss) on sale of building
--
--
--
--
--
--
--
--
--
1.09
Legal settlement
--
--
--
(0.13)
--
--
--
--
--
(1.80)
Change in fair value of earn-out
5.40
16.25
32.09
--
(9.00)
47.40
(20.40)
(8.00)
--
--
Total Operating Expenses
781.82
717.05
740.66
368.25
363.34
364.50
548.42
441.17
118.46
112.23
Operating Income (loss)
42.96
22.83
(42.90)
123.25
98.16
107.36
21.61
(15.08)
82.94
68.57
Interest expense
95.75
95.22
66.38
0.86
1.75
0.55
0.71
2.05
--
--
Investment income
--
--
--
--
--
--
--
--
--
--
Other income (loss)
(13.22)
(5.91)
(5.14)
0.80
1.09
7.90
1.47
(2.48)
0.77
1.13
Bargain purchase gain
--
--
--
--
--
--
--
70.89
1.46
--
Pre-Tax Income - Foreign
--
58.68
21.24
--
56.30
81.86
30.97
(8.59)
4.45
--
Pre-Tax Income: United States
--
(136.98)
(135.65)
--
41.19
32.85
(8.60)
59.87
80.71
--
Income Before Income Taxes And Minority Interest
(66.01)
(78.30)
(114.41)
123.19
97.49
114.71
22.37
51.28
85.16
69.70
Current-State
4.26
5.04
3.80
3.44
2.42
2.53
1.87
2.26
2.35
0.75
Deferred- Foreign
(10.48)
(13.78)
(7.72)
(1.31)
2.05
3.34
(5.72)
(0.07)
0.30
0.38
Deferred:Federal
1.29
(43.04)
(42.01)
(8.15)
(5.32)
(6.72)
(9.12)
(20.88)
(2.05)
4.52
Deferred:State
14.85
(14.66)
(11.24)
(1.82)
(1.85)
(0.33)
(3.07)
(4.62)
(0.77)
(0.96)
Provision for income taxes
51.68
(48.64)
(40.12)
20.05
10.62
13.67
(6.42)
(17.36)
22.08
24.71
Current-Federal
16.59
(8.24)
4.13
20.65
6.03
6.85
0.49
2.77
21.12
18.60
Current : Foreign
25.16
26.04
12.92
7.24
7.29
7.99
9.14
3.17
1.12
1.43
Minority interest
--
--
--
--
--
--
--
--
--
--
Net Income (Loss) Available to Common Shareholders
(117.69)
(29.66)
(74.29)
103.14
86.87
101.04
28.79
68.64
63.08
44.99
Net Earnings Per Share (Basic)
(4.83)
(1.23)
(3.11)
4.86
4.16
4.90
1.41
3.50
3.90
2.84
Net Earnings Per Share (Diluted)
(4.83)
(1.23)
(3.11)
4.74
4.02
4.69
1.33
3.29
3.66
2.73
Weighted Average Shares Outstanding (Basic)
24.39
24.09
23.87
21.21
20.91
20.63
20.39
19.61
16.17
15.85
Weighted Average Shares Outstanding (Diluted)
24.39
24.09
23.87
21.78
21.59
21.55
21.60
20.86
17.25
16.50